NSC |
Compound |
Enrichment |
Correlation |
NSC 711745 |
Null |
0.030556149892922 |
0.53057216 |
NSC 716768 |
Null |
0.030556149892922 |
0.12510194 |
NSC 719177 |
Benzoic acid, 4-[[(2,5-dihydroxyphenyl)methyl]amino]-, 1-adamantaneethyl ester |
0.030556149892922 |
0.44695188 |
NSC 724631 |
4,11-dihydroxy-1-[4-[[2-hydroxy-1-(hydroxymethyl)-1-methylet hyl]-mino]butyl]-1H-naphtho[2,3-f]indole-5,10-dione |
0.030556149892922 |
0.45387713 |
NSC 725191 |
1,6-bis[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(trifluorometh yl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexade c-9-en-9-yl]-3-hexene-1,6-diol |
0.030556149892922 |
0.5272862 |
NSC 734977 |
Ethyl N-[4-(10-methyl-3-phenyl-4H-indolo[3,2-e][1,2,3]triazolo [1,5-a]pyrimidin-4-yl)butanoyl]glycinate |
0.030556149892922 |
-0.13504171 |
NSC 735318 |
Null |
0.030556149892922 |
0.44331102 |
NSC 740602 |
Null |
0.030556149892922 |
0.60486614 |
NSC 741942 |
Null |
0.030556149892922 |
0.37499521 |
NSC 763646 |
(E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole |
0.030556149892922 |
0.53693285 |